世界の細胞計数市場 : 2029年までの予測

Report Overview

The global cell counting market was valued at US$9.98 billion in 2023. The market value is expected to reach US$15.72 billion by 2029. Cell counting is the process of determining the number of cells in a sample. It plays a crucial part in the clinical workflow in cell-based assays, spanning bioprocessing, cell and gene therapy (CGT), life science research to food/agriculture quality control.

The global cell counting market is witnessing significant growth due to various factors. Advancements in cell biology, biotechnology, and medical research are driving demand for precise cell counting, especially with the rise of personalized medicine and regenerative therapies. The expansion of biopharmaceutical and biotechnology sectors further fuels market growth. Future growth is anticipated due to technological advancements, including automation, artificial intelligence, and miniaturization, facilitating high-throughput analysis and integration with laboratory systems. Moreover, the focus on point-of-care diagnostics and decentralized testing, along with increasing healthcare investments and the prevalence of chronic diseases, will continue to propel market expansion. The market is expected to grow at a CAGR of approx. 8% during the forecasted period of 2024-2029.

Market Segmentation Analysis:

By Product: The report provides the bifurcation of the market into two segments based on the product: Consumables & Accessories, and Instrument. The consumables & accessories held the highest share in the market and is expected to be the fastest-growing segment in the forecasted period. Consumables and accessories play a crucial role in the cell counting process, supporting sample preparation, analysis, and data interpretation. As the volume of cell-based research and bioprocessing activities continues to increase, there is a corresponding rise in the demand for consumables such as cell counting chambers, slides, reagents, and disposable cuvettes.

By Application: The report further provides the segmentation based on the following applications: Life Science Research, Bioprocessing, Cell Based Therapy, and Others. Life science research segment held the highest share in the market, whereas the cell based therapy segment is expected to be the fastest-growing segment in the forecasted period. The demand for cell counting applications in cell-based therapy is increasing due to the rapid advancement and commercialization of cell-based treatments for various diseases and medical conditions. Cell counting is essential throughout the cell therapy development and manufacturing process, from initial research and development to clinical trials and commercialization. With the increasing focus on personalized medicine and regenerative therapies, there is a growing demand for accurate and reliable cell counting technologies to support the development and manufacturing of cell-based therapies tailored to individual patients.

By End-User: The report provides an analysis of the market based on end-users: Research & Academic Institutes, Hospitals & Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies, and Others. Research & academic institutes held the highest share in the market, whereas hospitals & diagnostic laboratories segment is expected to be the fastest growing segment in the forecasted period. The increasing emphasis on interdisciplinary research and collaborative initiatives has led to the integration of cell counting technologies into multidisciplinary research projects and academic consortia. As a result, research and academic institutes continue to invest in advanced cell counting instruments, consumables, and software tools to support their research endeavors, foster innovation, and train the next generation of scientists.

By Region: The report provides insight into the cell counting market based on the regions namely North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America held the major share in the market. In recent years, the cell and gene therapy market has grown significantly in the US. The increase in cell and gene therapy launches in the US creates a higher demand for accurate cell counting technologies throughout the therapy development process, from research and development to manufacturing and quality control. On the other hand, according to the National Cancer Institute, in 2020, an estimated 603,989 people were living with lung and bronchus cancer in the US. Therefore, the rise in solid tumor cases prompts an increase in active clinical trials for developing new treatments and therapies. These trials require extensive cell counting for patient monitoring, efficacy assessment, and safety evaluation, driving demand for cell counting technologies and contributing to market growth.

Germany has a robust healthcare system and a growing emphasis on personalized medicine, leading to increased investment in cell-based therapies for treating various diseases and medical conditions. The country’s supportive regulatory environment, coupled with government funding initiatives and collaborations between academia and industry, accelerates the adoption of cell counting technologies.

In October 2023, India’s counterpart to the US Food and Drug Administration, the Central Drugs Standard Control Organization, made NexCAR19 India’s first approved CAR-T cell therapy. The approval of new cell therapies drives demand for cell counting technologies used in therapy development, manufacturing, and patient monitoring. This increased adoption of cell counting solutions contributes to Indian market growth.

Market Dynamics:

Growth Drivers: The global cell counting market has been growing over the past few years, due to factors such as an increasing number of active cell and gene therapy trials, rising spending on pharmaceutical R&D, funding in the biopharma sector, developments in advanced cell-based research, government initiatives for promoting cell therapeutics research, and many other factors. CGT is a relatively new type of niche that has the potential to treat many diseases for which there is currently no effective alternative. While decades of research have gone into CGT, developing this innovative treatment gathered momentum after the FDA approved the first CAR-T therapy in 2017 (Novartis’s Kymriah for acute lymphoblastic leukemia). The increasing number of active cell and gene therapy trials has driven the demand for advanced cell counting technologies and solutions. Cell and gene therapies require precise characterization and quantification of therapeutic cells, vectors, and target cells, both during manufacturing processes and in preclinical and clinical studies. As the field of regenerative medicine expands and more therapies move towards commercialization, there is a growing need for accurate and reliable cell counting instruments, flow cytometry systems, and image-based analysis platforms.

Challenges: However, the market growth would be negatively impacted by various challenges such as high cost of cell analysis, sample heterogeneity, etc.

Trends: The market is projected to grow at a fast pace during the forecast period, due to various latest trends such as growing number of new clinical trials, rising demand for personalized medicine, advancements in cell counting technologies, shift towards portable and point-of-care cell counting devices, integration of AI and ML, increasing adoption of automation, etc. Cell counting instrument sales growth is tightly connected to the number of CGT approvals. At the end of May 2023, Krystal Biotech’s Vyjuvek – a gene therapy for the treatment of dystrophic epidermolysis bullosa (DEB) – received FDA approval. On the other hand, at the end of June 2023, Sarepta Therapeutics received FDA approval for its Duchenne muscular dystrophy (DMD) treatment. The FDA has missed most of its PDUFA target dates in the CGT area during 2023. However, the Center for Biologics Evaluation and Research (CBER), the arm of the FDA that evaluates CGT therapies, has been authorized to hire another 125 reviewers under PDUFA VII. Such an expansion could help the administration meet its target deadlines, going forward. PDUFA dates for therapies could translate into an order book boost for the cell counting players in the market, resulting in market growth.

Impact Analysis of COVID-19 and Way Forward:

The COVID-19 pandemic created opportunities for the cell counting market. With the urgent need for diagnostic testing and vaccine development, there was a surge in demand for cell counting instruments and reagents used in virology research. Furthermore, the pandemic underscored the critical role of cell counting in various aspects of infectious disease management, from basic research on viral replication mechanisms to clinical applications such as immune cell profiling and vaccine development. This increased recognition is likely to drive sustained demand for cell counting instruments and reagents in the coming years, as stakeholders prioritize preparedness for future outbreaks and invest in strengthening healthcare infrastructure.

Competitive Landscape:

The global cell counting market is consolidated, with top five players holding approximately 70% share of the market. The key players in the global cell counting market are:

ChemoMetec
Thermo Fisher Scientific Inc.
Merck KGaA (MilliporeSigma)
Agilent Technologies, Inc.
Revvity Inc. (Nexcelom Bioscience LLC.)
Bio-Rad Laboratories, Inc.
Becton, Dickinson and Company
Danaher Corporation (Beckman Coulter Inc.)
Olympus Corporation
Sysmex Corporation
Aligned Genetics, Inc. (Logos Biosystems)
DeNovix Inc.

Some of the strategies among key players in the market are product launches, mergers, acquisitions, and collaborations. For instance, BD Biosciences, a subsidiary of Becton Dickinson, released the Accuri C6, in 2018. This is one of the company’s simpler and more compact cytometers. Backed by 23,000 citations to date, the instrument is widely used in most types of bioprocessing workflows, such as cell and cancer biology, plant and microbiology, and industrial applications. On the other hand, Beckman Coulter offers two versions of its Vi-CELL cell counter: the Vi-CELL BLU and Vi-CELL XR (the BLU is a more advanced version of the older XR, able to process more samples faster (and able to work with smaller sample volumes)). Both support a 24-sample carousel or a 96 well plate, making them ideal for bioprocessing applications.

Table of Contents

1. Executive Summary

2. Introduction

2.1 Cell Counting: An Overview
2.1.1 Introduction to Cell Counting
2.1.2 Manual v/s Automated Cell Counting
2.1.3 Type of Automated Cell Counting Technologies
2.1.4 Pros and Cons of Manual v/s Automated Cell Counting

2.2 Cell Counting Segmentation: An Overview

3. Global Market Analysis

3.1 Global Cell Counting Market: An Analysis

3.1.1 Global Cell Counting Market: An Overview
3.1.2 Global Cell Counting Market by Value
3.1.3 Global Cell Counting Market by Product (Consumables & Accessories, and Instrument)
3.1.4 Global Cell Counting Market by Application (Life Science Research, Bioprocessing, Cell Based Therapy, and Others)
3.1.5 Global Cell Counting Market by End-User (Research & Academic Institutes, Hospitals & Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies, and Others)
3.1.6 Global Cell Counting Market by Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa)

3.2 Global Cell Counting Market: Product Analysis

3.2.1 Global Cell Counting Market by Product: An Overview
3.2.2 Global Cell Counting Consumables & Accessories Market by Value
3.2.3 Global Cell Counting Instrument Market by Value

3.3 Global Cell Counting Market: Application Analysis

3.3.1 Global Cell Counting Market by Application: An Overview
3.3.2 Global Life Science Research Cell Counting Market by Value
3.3.3 Global Bioprocessing Cell Counting Market by Value
3.3.4 Global Cell Based Therapy Cell Counting Market by Value
3.3.5 Global Others Cell Counting Market by Value

3.4 Global Cell Counting Market: End-User Analysis

3.4.1 Global Cell Counting Market by End-User: An Overview
3.4.2 Global Research and Academic Institutes Cell Counting Market by Value
3.4.3 Global Hospitals & Diagnostic Laboratories Cell Counting Market by Value
3.4.4 Global Pharmaceutical and Biotechnology Companies Cell Counting Market by Value
3.4.5 Global Others Cell Counting Market by Value

4. Regional Market Analysis

4.1 North America Cell Counting Market: An Analysis

4.1.1 North America Cell Counting Market: An Overview
4.1.2 North America Cell Counting Market by Value
4.1.3 North America Cell Counting Market by Region (the US, Canada, and Mexico)
4.1.4 The US Cell Counting Market by Value
4.1.5 The US Cell Counting Market by Product (Consumables & Accessories, and Instrument)
4.1.6 The US Cell Counting Consumables & Accessories Market by Value
4.1.7 The US Cell Counting Instrument Market by Value
4.1.8 Canada Cell Counting Market by Value
4.1.9 Mexico Cell Counting Market by Value

4.2 Europe Cell Counting Market: An Analysis

4.2.1 Europe Cell Counting Market: An Overview
4.2.2 Europe Cell Counting Market by Value
4.2.3 Europe Cell Counting Market by Region (Germany, The UK, France, Spain, Italy, and Rest of the Europe)
4.2.4 Germany Cell Counting Market by Value
4.2.5 The UK Cell Counting Market by Value
4.2.6 France Cell Counting Market by Value
4.2.7 Spain Cell Counting Market by Value
4.2.8 Italy Cell Counting Market by Value
4.2.9 Rest of Europe Cell Counting Market by Value

4.3 Asia Pacific Cell Counting Market: An Analysis

4.3.1 Asia Pacific Cell Counting Market: An Overview
4.3.2 Asia Pacific Cell Counting Market by Value
4.3.3 Asia Pacific Cell Counting Market by Region (China, Japan, India, South Korea, and Rest of the Asia Pacific)
4.3.4 China Cell Counting Market by Value
4.3.5 Japan Cell Counting Market by Value
4.3.6 India Cell Counting Market by Value
4.3.7 South Korea Cell Counting Market by Value
4.3.8 Rest of Asia Pacific Cell Counting Market by Value

4.4 Latin America Cell Counting Market: An Analysis

4.4.1 Latin America Cell Counting Market: An Overview
4.4.2 Latin America Cell Counting Market by Value

4.5 Middle East & Africa Cell Counting Market: An Analysis

4.5.1 Middle East & Africa Cell Counting Market: An Overview
4.5.2 Middle East & Africa Cell Counting Market by Value

5. Impact of COVID-19

5.1 Impact of COVID-19 on Global Cell Counting Market
5.2 Post COVID-19 Impact on Global Cell Counting Market

6. Market Dynamics

6.1 Growth Drivers
6.1.1 Increasing Sale of Cell and Gene Therapy Products
6.1.2 Rising Spending on Pharmaceutical R&D
6.1.3 Aging Population
6.1.4 Funding in Biopharma Sector
6.1.5 Developments in Advanced Cell Based Research
6.1.6 Increasing Prevalence of Chronic and Infectious Diseases
6.1.7 Government Initiatives for Promoting Cell Therapeutics Research

6.2 Challenges
6.2.1 High Cost of Cell Analysis
6.2.2 Sample Heterogeneity

6.3 Market Trends
6.3.1 Increasing Number of Active Cell and Gene Therapy Trials
6.3.2 Growing Number of New Clinical Trials
6.3.3 Rising Demand for Personalized Medicine 
6.3.4 Cell and Gene Therapy Pipeline
6.3.5 Advancements in Cell Counting Technologies
6.3.6 Increasing Adoption of Automation
6.3.7 Shift Towards Portable and Point-of-Care Cell Counting Devices
6.3.8 Integration of AI and ML

7. Competitive Landscape

7.1 Global Cell Counting Players by Market Share
7.2 Global Cell Counting Players by Product Comparison
7.3 Global Cell Counting Players by Low Throughput Offerings
7.4 Global Cell Counting Players by High Throughput Offerings
7.5 Global Cell Counting Players by Bioprocessing Cell Counters and Analyzers

8. Company Profiles

8.1 ChemoMetec
8.1.1 Business Overview
8.1.2 Revenue by Business Area
8.1.3 Business Strategy

8.2 Thermo Fisher Scientific Inc.
8.2.1 Business Overview
8.2.2 Operating Segments
8.2.3 Business Strategy

8.3 Merck KGaA (MilliporeSigma)
8.3.1 Business Overview
8.3.2 Operating Segments
8.3.3 Business Strategy

8.4 Agilent Technologies, Inc.
8.4.1 Business Overview
8.4.2 Operating Segments
8.4.3 Business Strategy

8.5 Revvity Inc. (Nexcelom Bioscience LLC.)
8.5.1 Business Overview
8.5.2 Operating Segments
8.5.3 Business Strategy

8.6 Bio-Rad Laboratories, Inc.
8.6.1 Business Overview
8.6.2 Operating Segments
8.6.3 Business Strategy

8.7 Becton, Dickinson and Company
8.7.1 Business Overview
8.7.2 Operating Segments
8.7.3 Business Strategy

8.8 Danaher Corporation (Beckman Coulter Inc.)
8.8.1 Business Overview
8.8.2 Operating Segments
8.8.3 Business Strategy

8.9 Olympus Corporation
8.9.1 Business Overview
8.9.2 Operating Segments
8.9.3 Business Strategy

8.10 Sysmex Corporation
8.10.1 Business Overview
8.10.2 Operating Regions
8.10.3 Business Strategy

8.11 Aligned Genetics, Inc. (Logos Biosystems)
8.11.1 Business Overview
8.11.2 Business Strategy

8.12 DeNovix Inc.
8.12.1 Business Overview
8.12.2 Business Strategy

List of Figures

Figure 1: Type of Automated Cell Counting Technologies
Figure 2: Pros and Cons of Manual v/s Automated Cell Counting
Figure 3: Cell Counting Segmentation
Figure 4: Global Cell Counting Market by Value; 2019-2023 (US$ Billion)
Figure 5: Global Cell Counting Market by Value; 2024-2029 (US$ Billion)
Figure 6: Global Cell Counting Market by Product; 2023 (Percentage, %)
Figure 7: Global Cell Counting Market by Application; 2023 (Percentage, %)
Figure 8: Global Cell Counting Market by End-User; 2023 (Percentage, %)
Figure 9: Global Cell Counting Market by Region; 2023 (Percentage, %)
Figure 10: Global Cell Counting Consumables & Accessories Market by Value; 2019-2023 (US$ Billion)
Figure 11: Global Cell Counting Consumables & Accessories Market by Value; 2024-2029 (US$ Billion)
Figure 12: Global Cell Counting Instrument Market by Value; 2019-2023 (US$ Billion)
Figure 13: Global Cell Counting Instrument Market by Value; 2024-2029 (US$ Billion)
Figure 14: Global Life Science Research Cell Counting Market by Value; 2019-2023 (US$ Billion)
Figure 15: Global Life Science Research Cell Counting Market by Value; 2024-2029 (US$ Billion)
Figure 16: Global Bioprocessing Cell Counting Market by Value; 2019-2023 (US$ Billion)
Figure 17: Global Bioprocessing Cell Counting Market by Value; 2024-2029 (US$ Billion)
Figure 18: Global Cell Based Therapy Cell Counting Market by Value; 2019-2023 (US$ Million)
Figure 19: Global Cell Based Therapy Cell Counting Market by Value; 2024-2029 (US$ Billion)
Figure 20: Global Others Cell Counting Market by Value; 2019-2023 (US$ Million)
Figure 21: Global Others Cell Counting Market by Value; 2024-2029 (US$ Million)
Figure 22: Global Research and Academic Institutes Cell Counting Market by Value; 2019-2023 (US$ Billion)
Figure 23: Global Research and Academic Institutes Cell Counting Market by Value; 2024-2029 (US$ Billion)
Figure 24: Global Hospitals & Diagnostic Laboratories Cell Counting Market by Value; 2019-2023 (US$ Billion)
Figure 25: Global Hospitals & Diagnostic Laboratories Cell Counting Market by Value; 2024-2029 (US$ Billion)
Figure 26: Global Pharmaceutical and Biotechnology Companies Cell Counting Market by Value; 2019-2023 (US$ Billion)
Figure 27: Global Pharmaceutical and Biotechnology Companies Cell Counting Market by Value; 2024-2029 (US$ Billion)
Figure 28: Global Others Cell Counting Market by Value; 2019-2023 (US$ Billion)
Figure 29: Global Others Cell Counting Market by Value; 2024-2029 (US$ Billion)
Figure 30: North America Cell Counting Market by Value; 2019-2023 (US$ Billion)
Figure 31: North America Cell Counting Market by Value; 2024-2029 (US$ Million)
Figure 32: North America Cell Counting Market by Region; 2023 (Percentage, %)
Figure 33: The US Cell Counting Market by Value; 2019-2023 (US$ Billion)
Figure 34: The US Cell Counting Market by Value; 2024-2029 (US$ Billion)
Figure 35: The US Cell Counting Market by Product; 2023 (Percentage, %)
Figure 36: The US Cell Counting Consumables & Accessories Market by Value; 2019-2023 (US$ Billion)
Figure 37: The US Cell Counting Consumables & Accessories Market by Value; 2024-2029 (US$ Billion)
Figure 38: The US Cell Counting Instrument Market by Value; 2019-2023 (US$ Billion)
Figure 39: The US Cell Counting Instrument Market by Value; 2024-2029 (US$ Billion)
Figure 40: Canada Cell Counting Market by Value; 2019-2023 (US$ Million)
Figure 41: Canada Cell Counting Market by Value; 2024-2029 (US$ Million)
Figure 42: Mexico Cell Counting Market by Value; 2019-2023 (US$ Million)
Figure 43: Mexico Cell Counting Market by Value; 2024-2029 (US$ Million)
Figure 44: Europe Cell Counting Market by Value; 2019-2023 (US$ Billion)
Figure 45: Europe Cell Counting Market by Value; 2024-2029 (US$ Billion)
Figure 46: Europe Cell Counting Market by Region; 2023 (Percentage, %)
Figure 47: Germany Cell Counting Market by Value; 2019-2023 (US$ Million)
Figure 48: Germany Cell Counting Market by Value; 2024-2029 (US$ Billion)
Figure 49: The UK Cell Counting Market by Value; 2019-2023 (US$ Million)
Figure 50: The UK Cell Counting Market by Value; 2024-2029 (US$ Million)
Figure 51: France Cell Counting Market by Value; 2019-2023 (US$ Million)
Figure 52: France Cell Counting Market by Value; 2024-2029 (US$ Million)
Figure 53: Spain Cell Counting Market by Value; 2019-2023 (US$ Million)
Figure 54: Spain Cell Counting Market by Value; 2024-2029 (US$ Million)
Figure 55: Italy Cell Counting Market by Value; 2019-2023 (US$ Million)
Figure 56: Italy Cell Counting Market by Value; 2024-2029 (US$ Million)
Figure 57: Rest of Europe Cell Counting Market by Value; 2019-2023 (US$ Million)
Figure 58: Rest of Europe Cell Counting Market by Value; 2024-2029 (US$ Million)
Figure 59: Asia Pacific Cell Counting Market by Value; 2019-2023 (US$ Billion)
Figure 60: Asia Pacific Cell Counting Market by Value; 2024-2029 (US$ Billion)
Figure 61: Asia Pacific Cell Counting Market by Region; 2023 (Percentage, %)
Figure 62: China Cell Counting Market by Value; 2019-2023 (US$ Million)
Figure 63: China Cell Counting Market by Value; 2024-2029 (US$ Billion)
Figure 64: Japan Cell Counting Market by Value; 2019-2023 (US$ Million)
Figure 65: Japan Cell Counting Market by Value; 2024-2029 (US$ Million)
Figure 66: India Cell Counting Market by Value; 2019-2023 (US$ Million)
Figure 67: India Cell Counting Market by Value; 2024-2029 (US$ Million)
Figure 68: South Korea Cell Counting Market by Value; 2019-2023 (US$ Million)
Figure 69: South Korea Cell Counting Market by Value; 2024-2029 (US$ Million)
Figure 70: Rest of Asia Pacific Cell Counting Market by Value; 2019-2023 (US$ Million)
Figure 71: Rest of Asia Pacific Cell Counting Market by Value; 2024-2029 (US$ Million)
Figure 72: Latin America Cell Counting Market by Value; 2019-2023 (US$ Million)
Figure 73: Latin America Cell Counting Market by Value; 2024-2029 (US$ Million)
Figure 74: Middle East & Africa Cell Counting Market by Value; 2019-2023 (US$ Million)
Figure 75: Middle East & Africa Cell Counting Market by Value; 2024-2029 (US$ Million)
Figure 76: Global Sale of Cell and Gene Therapy Products; 2018-2026 (US$ Billion)
Figure 77: Global Spending on Pharmaceutical Research and Development; 2019-2028 (US$ Billion)
Figure 78: Global Percentage of Population Aged 65 Years or Above; 2022, 2030 & 2050 (Percentage, %)
Figure 79: Global Biotech Venture Capital Funding-Series A Onwards; 2019-2023 (US$ Billion)
Figure 80: Global Active CGT Trials; 2015-2022 (Thousand)
Figure 81: Global Number of New Clinical Trials; 2019-2026 (Percentage, %, Thousand)
Figure 82: Global Cell Counting Players by Market Share; 2023 (Percentage, %)
Figure 83: ChemoMetec Revenue by Business Area; 2022/23 (Percentage, %)
Figure 84: Thermo Fisher Scientific Inc. Revenue by Segment; 2023 (Percentage, %)
Figure 85: Merck KGaA Net Sales by Segment; 2022 (Percentage, %)
Figure 86: Agilent Technologies, Inc. Net Revenue by Segment; 2023 (Percentage, %)
Figure 87: Revvity Inc. Revenue by Segment; 2023 (Percentage, %)
Figure 88: Bio-Rad Laboratories, Inc. Net Sales by Segments; 2023 (Percentage, %)
Figure 89: Becton, Dickinson and Company Revenues by Segment; 2023 (Percentage, %)
Figure 90: Danaher Corporation Revenue by Segment; 2023 (Percentage, %)
Figure 91: Olympus Corporation Revenue by Segment; 2023 (Percentage, %)
Figure 92: Sysmex Corporation Net Sales by Region; 2023 (Percentage, %)
Table 1 : CGT Pipeline, 2023-24
Table 2: Global Cell Counting Players by Product Comparison
Table 3: Global Cell Counting Players by Low Throughput Offerings
Table 4: Global Cell Counting Players by High Throughput Offerings
Table 5: Global Cell Counting Players by Bioprocessing Cell Counters and Analyzers